rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Protects Against Gut Damage Even Without Stomach Acid Present

RPEP-004291997Sikirić, P; Mikus, D; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Perić, J; Konjevoda, P; Perović, D; Jurina, L; Hanzevacki, M; Separović, J; Gjurasin, M; Jadrijević, S; Jelovac, N; Miklić, P; Buljat, G; Marović, A
Animal StudyPreliminary evidence
The takeaway

BPC-157 showed cytoprotective effects in totally gastrectomized rats where no stomach acid is present, proving its protective mechanism is independent of acid reduction.

Acid-independent protection

BPC-157 protected against gut damage in rats with no stomach (no acid), proving direct cytoprotection

What the researchers found

BPC-157 demonstrated cytoprotective effects in totally gastrectomized (acid-free) rats, proving its mechanism is independent of acid reduction.

Why it matters

This proves BPC-157 is a true cytoprotective agent — it protects cells directly, not by reducing acid. This fundamentally different mechanism from antacids means it could help with damage that acid-reducing drugs cannot.

How the study worked

Total gastrectomy in rats to create an acid-free environment. Cysteamine-induced lesions were then treated with BPC-157, cimetidine, ranitidine, bromocriptine, or atropine and compared.

What this study cannot tell us

Total gastrectomy creates an artificial model. The absence of a stomach changes many physiological parameters beyond just acid. Comparison drug results not detailed in abstract.

How to read the evidence

Moderate animal evidence using a creative experimental model to definitively separate acid reduction from cytoprotection.

When this study was published

Published in 1997, establishing that BPC-157's mechanism is fundamentally different from acid-suppressing drugs.

The bigger picture

Most gut-protective drugs work by reducing acid. BPC-157's acid-independent mechanism means it could protect against gut damage from causes other than acid, including NSAIDs, alcohol, and stress.

Questions still open

  • What is BPC-157's direct cytoprotective mechanism at the cellular level?
  • Could BPC-157 replace acid-suppressing drugs for conditions where acid isn't the primary cause of damage?

Common questions

How is BPC-157 different from antacids?
Antacids and H2 blockers (like ranitidine) reduce stomach acid. BPC-157 protects cells directly — even when there's zero acid present (as in this gastrectomy model). This means it addresses a different cause of gut damage.
What does cytoprotection mean?
Cytoprotection literally means 'cell protection.' It refers to protecting cells from damage through mechanisms other than removing the harmful agent (like acid). BPC-157 appears to strengthen cells' ability to resist damage from multiple sources.

Read the original research

Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.

Digestive diseases and sciences, 42(5), 1029-37

View on PubMed ↗

Citation

Sikirić, P; Mikus, D; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Perić, J; Konjevoda, P; Perović, D; Jurina, L; Hanzevacki, M; Separović, J; Gjurasin, M; Jadrijević, S; Jelovac, N; Miklić, P; Buljat, G; Marović, A. (1997). Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.. Digestive diseases and sciences, 42(5), 1029-37.